ClinicalTrials.govpublic full text
Treatment Shortening of MDR-TB Using Existing and New Drugs
tuberculosis, multidrug-resistant, multidrug-resistant tuberculosis, linezolid, delamanid, multicenter randomized trial, non-inferiority, shorter regimen, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 834637
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.